Q2 Review: After Weak Q2, Can Biocon Bounce Back In Q3? | BQPrime
#Q2WithBQ | Biocon's second-quarter profit falls due to a tax write-off; margins come under pressure as well. MD & CEO Siddharth Mittal shares growth strategy and plans for FY23. #BQLive
AMFI CEO On November Mutual Fund Inflows
Dec 09, 2022
Indian Markets At 'High Valuations'; How Long Will Outperformance Last? | Talking Point
Dec 09, 2022
HCL Tech Tumbles In Trade After Management Lowers Guidance
Dec 09, 2022
Show All